CDI - Key Persons
Job Titles:
- Director of Systems Engineering
- UW Center for Dialysis Innovation Director of Systems Engineering
Barry N. Fulkerson is the UW Center for Dialysis Innovation Director of Systems Engineering and a Medical Products R&D Executive, offering direct medical device innovation and product development experience developing extracorporeal systems in start-up and established environments. Based on partnerships with clinicians, Barry designed progressive therapies that meet clinical and patient needs in an ever-evolving reimbursement environment. Barry has been a Principal at Purewater Medical since 2015, developing novel water purification technology. Previously, Barry was the VP of Operations and R&D with Fresenius Medical Care North America (2010-2016), the VP of R&D for Xcorporeal (2007-2010) which was acquired by Fresenius Medical Care North America, Director of Electrical and Software Development with NxStage Medical (1999-2006), an R&D Software Development Engineer with Gambro BCT (1995-1999), and a various systems, field support, manufacturing, and quality engineering roles at Gambro's Renal Products division (1986-1995).
Job Titles:
- Chief of Vascular Surgery, Department
- Chief of Vascular Surgery, Department of Surgery, UW Medicine / Program Director, Vascular Surgery Fellowship, University of Washington
Chief of Vascular Surgery, Department of Surgery, UW Medicine Program Director, Vascular Surgery Fellowship, University of Washington Alexander Whitehill Clowes Endowed Chair & Professor, Department of Surgery, Division of Vascular Surgery, University of Washington Dr. Starnes is a board certified
Dr. Starnes is a board certified vascular surgeon at Harborview and Valley Medical Center, Chief of Vascular Surgery for UW Medicine, program director for the UW Vascular Surgery Fellowship, the UW's Alexander Whitehill Clowes Endowed Chair in Vascular Surgery and a UW professor of Vascular Surgery. Dr. Starnes is an internationally recognized expert in aortic disease and vascular trauma. He strives to create active partnerships with his patients to achieve the best possible outcomes. Dr. Starnes earned his MD at Jefferson Medical College, Philadelphia. He served 15 years in the US Army, including three combat tours. His clinical interests include ruptured aortic aneurysms, blunt traumatic aortic injury, aortic dissection and vascular trauma. His research interests include multi-branch and fenestrated endografting for complex aortic disease, vascular trauma and factors that influence outcomes for patients with ruptured abdominal aortic aneurysm.
Research Interests:
Multi-branch and fenestrated endografting for complex aortic disease
Factors that influence outcomes for patients presenting with ruptured abdominal aortic aneurysm
Vascular Trauma
Education & Training: Jefferson Medical College Medical Education, 1992
Uniformed Services Teaching Appointment, Walter Reed Army Medical Center
Fellowship, Walter Reed Army Medical Center
Internship, Walter Reed Army Medical Center Residency
Bruce Hinds is the Campbell Professor in the Department of Materials Science & Engineering at the University of Washington. He researches nanostructures and nanoscale fabrication, such as electronics fabrication at the molecular level and novel technologies for nano-lithography. He has received an NSF Early Career Award, Presidential Early Career Award, and a Kavli Frontiers of Science Fellowship from the National Academy of Science.
Research Interests:
Making active nanometer-scale material architectures with engineering membranes
Education & Training: Ph.D., Inorganic Chemistry, Northwestern University, 1996
M.S., Chemistry, Northwestern University, 1992
B.S., Chemistry, Harvey Mudd College, 1991 External: View publications
Job Titles:
- Biomaterials & CDI Co - Director
- Co - Director of the UW Center for Dialysis Innovation
Buddy Ratner is Co-Director of the UW Center for Dialysis Innovation, Director of the Engineered Biomaterials Engineering Research Center, holds the Michael L. and Myrna Darland Endowed Chair in Technology Commercialization, and is Professor in Bioengineering and Chemical Engineering at UW. He is an expert in biomaterials used in medical devices and implants, and is a Fellow and past President of the American Institute of Medical and Biological Engineering (AIMBE), past President of the Society for Biomaterials, as well as a member of the National Academy of Engineering, and the American Association for the Advancement of Science. His numerous awards include the 2014 Lifetime Inventor and Innovator Award from the University of Washington.
Research Interests:
Synthesis and characterization of polymeric biomaterials
Surface analysis by ESCA, SIMS, STM, FTIR-ATR, AFM
Plasma deposition of thin films
Education & Training: Postdoctoral Fellow, Chemical Engineering, U. Washington, 1972-1973
Dr. Buddy Ratner, PhD, is Co-Director of CDI, Director of the Engineered Biomaterials Engineering Research Center, Michael L. and Myrna Darland Endowed Chair in Technology Commercialization, and Professor in Bioengineering and Chemical Engineering at the University of Washington.
Curtis Warfield is a Senior Quality Analyst. In 2012 Curtis was diagnosed with stage 3 Chronic Kidney Disease. In January 2016, he received a kidney from a living donor, his daughter's sorority sister. Curtis gives back to the community by bringing awareness to kidney disease and the need for organ donors. Curtis is a regional leader of National Kidney Foundation's Kidney Advocacy Committee, a peer mentor and volunteers to speak with legislators both on Capitol Hill and the Indiana State Legislature about kidney disease and organ transplantation. He serves on several committees, technical and medical review panels. He is co-chair of NKF's Patient Diversity Workgroup and patient stakeholder of NKF/ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases. Curtis servers on the Board of Directors of National Kidney Foundation of Indiana and Home Dialyzors United. Curtis is a patient advocate with Patient-Centered Outcomes Research Institute, American Association of Kidney Patients, Donate Life Indiana, UNOS, Chronic Disease Coalition and American Kidney Fund. He does public speaking, writes articles and blogs, about kidney disease and organ donation. Curtis is the 2021 recipient of the NKF Celeste Castillo Lee Patient Engagement Award, NKF's highest honor to a distinguished kidney patient volunteer. Curtis has a B.S. degree from Central Michigan University, and M.S. from Oakland City University. Curtis is married, has 4 children, and a grandchild.
David A. Stahl is a Professor in Civil and Environmental Engineering and an Adjunct Professor in Microbiology at the University of Washington. He is well known for his research on the physiological ecology of microorganisms sustaining critical nutrient cycles (N, C, S) in natural and engineered systems. He is the co-founding editor of the journal Environmental Microbiology and is one of the authors of the well-known textbook Brock Biology of Microorganisms. He is a member of the American Academy of Microbiology, the DOE Biological and Environmental Research Advisory Committee and served as the Chief Scientist for the Environmental Molecular Sciences Laboratory, at the Pacific Northwest National Laboratory. In 2012, he was elected to the National Academy of Engineering.
David H. Koch Institute Professor, Massachusetts Institute of Technology Germeshausen Professor of Chemical & Biomedical Engineering, Massachusetts Institute of Technology Dr. Langer, MD, PhD, is the David H. Koch Institute Professor at MIT, the highest honor that can be awarded
Job Titles:
- Senior Consultant With Biologics Consulting Group
Dr.Tillman, PhD, is a Senior Consultant with Biologics Consulting Group, where she helps clients navigate the FDA regulatory pathways, regulatory requirements, short and long term regulatory strategies, and assists clients with FDA interactions to increase the availability of safe and effective medical devices and combination products. Dr. Tillman is a biomedical engineer with more than 20 years of medical device regulatory experience, including 17 years at the FDA. Dr. Tillman is a former director of the FDA CDRH Office of Device Evaluation, and has broad expertise in medical device regulatory affairs. At the FDA she led a team of 375 scientists and clinicians responsible for the premarket review of medical devices in the US, planned, implemented, and monitored programs to achieve center and agency strategic initiatives, and provided executive leadership for the development of a regulatory framework addressing health information systems. Prior to this position, Dr. Tillman served as Deputy Director for the Office of Device Evaluation, Deputy Division Director for the Division of Cardiovascular Devices, and Chief of the Branch of Pacing and Electrophysiology Devices at the FDA, where she developed programs for the implementation of the Medical Device Modernization and User Fee Act, managed the medical device regulatory review program, and provided scientific and regulatory oversight of the review work of DCD branches, particularly with regard to novel, complex, and problematic issues. Dr. Tillman is also recognized as a thought-leader in the area of medical device regulatory requirements for software, and spent 2 years as the Director of Regulations and Policy at Microsoft establishing a medical device regulatory and quality program, managing premarket submissions and product registrations in the US and internationally, and overseeing the post-market safety program. Dr. Tillman became a Fellow of the Regulatory Affairs Professional Society in 2012, one of 12 highly accomplished professionals working in the healthcare product regulatory field honored that year. Dr. Tillman received a BS in bioengineering from Tulane University, a MPA in public administration from American University, and a PhD in biomedical engineering from Johns Hopkins University.
Job Titles:
- Director of Research & Development
- UW Center for Dialysis Innovation Director of Research and Development
Dr. Anna Galperin, PhD, is CDI's Director of Research and Development. She received her MSc in Medicinal Organic Chemistry in 2000 and graduated with a PhD in Polymer Chemistry in 2006 from Bar-Ilan University, Israel.
Anna Galperin is the UW Center for Dialysis Innovation Director of Research and Development. She received her MSc in Medicinal Organic Chemistry in 2000 and graduated with a PhD in Polymer Chemistry in 2006 from Bar-Ilan University, Israel, where she was awarded the "Eshkol Fellowship for Outstanding Graduate Student" from the Israeli Ministry of Science and Technology. In 2008, Dr. Galperin moved to Seattle to complete her postdoctoral research in the Department of Bioengineering at the University of Washington, under the guidance of Professor Buddy Ratner. Upon completion in 2013, Dr. Galperin continued to pursue her career in industry. She is the author of 16 peer-reviewed publications and co-author of several patents and book chapters. Dr. Galperin possesses a uniquely multidisciplinary experience that spans fields such as polymer chemistry, medicinal and analytical chemistry as well as bioengineering. She developed her diverse expertise through a successful career in academia and industry; in both settings her work combined drug-delivery platforms for imaging, tissue engineering, and the development of new treatments for Alzheimer's disease and genetic disorders. Dr. Galperin holds a Certificate in Biotechnology Project Management and a Certificate in Biomedical Regulatory Affairs from the University of Washington.
Dr. Gao has published over 500 peer-reviewed research articles (including over 250 full journal papers), over 40 scientific book chapters, and many US and international patents. Currently, he serves as Editor-in-Chief of the Journal of Electronics Cooling and Thermal Control, Deputy Editor of the Biopreservation and Biobanking Journal, and Editorial Board Member of other 9 scientific journals. Dr. Gao has been actively invited as a plenary or keynote speaker, presenting at major conferences, research institutions, and universities worldwide. He has delivered over 200 scientific meeting presentations. He has trained and supervised over 200 graduate students, post-doctoral fellows, visiting professors, and research scientists/technologists.
Dr. Gao is a recipient of numerous international/national honors and awards. He is the elected Member of the Washington State Academy of Sciences, Fellow of American Institute of Medical and Biological Engineering, Fellow of American Society of Mechanical Engineers, and Fellow of the Society for Cryobiology with the Basil J. Luyet Medal. Most recently, the Dayong Gao Young Investigator Award has been named and established by the Society for Cryobiology to recognize the most outstanding young cryobiologist or cryo-biomedical engineer worldwide, every year from 2019. (https://www.societyforcryobiology.org/dayong-gao-young-investigator-award).
Job Titles:
- Co - Director
- Co - Director of the Center for Dialysis Innovation
- Co - Director of the UW Center for Dialysis Innovation
- Nephrology & CDI Co - Director )
Dr. Jonathan Himmelfarb, MD, is Co-Director of the Center for Dialysis Innovation, Director of the Kidney Research Institute, Joseph W. Eschbach, MD Endowed Chair in Kidney Research, and Professor of Medicine in Nephrology at the University of Washington.
Jonathan Himmelfarb is Co-Director of the UW Center for Dialysis Innovation, Director of the Kidney Research Institute, Professor of Medicine and Adjunct Professor of Bioengineering, and holds the Joseph W. Eschbach M.D. Endowed Chair in Kidney Research at UW. He is a leading expert on uremia, altered metabolism in kidney disease, and in hemodialysis. He is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), and the American Society of Nephrology, and has held leadership roles in multiple NIH funded consortia, including the NIDDK Kidney Precision Medicine Project and the NCATS Tissue Chips Consortium. Dr. Himmelfarb has held leadership positions in many national and international nephrology organizations, including serving as President of the ASN in 2014-2015. He has served on expert panels for the U.S. Food and Drug Administration, Veterans Health Administration, Centers for Medicare & Medicaid Services and other organizations.
Research Interests:
Oxidative stress and inflammation in chronic kidney disease
Biomarkers of cardiovascular risk in kidney disease
Dialysis vascular access
Mechanisms of proteinuria
Education & Training: Nephrology Fellowship (1988-89), Maine Medical Center, Portland, ME
Nephrology Fellowship (1986-88), Brigham & Women's Hospital, Boston, MA
Medicine Residency (1983-86), Maine Medical Center, Portland, ME
Medical School (1979-83), George Washington University, Washington, DC External: View publications
Job Titles:
- CEO and Co - Founder of Carbon, Inc
CEO & Co-Founder, Carbon, Inc. Chancellor's Eminent Professor of Chemistry, UNC-Chapel Hill William R. Kenan Jr. Distinguished Professor of Chemical Engineering at North Carolina State University and of Chemistry at UNC-Chapel Hill Dr. Joseph M. DeSimone is the CEO and
Dr. Joseph M. DeSimone is the CEO and co-founder of Carbon, Inc., a Silicon Valley-based company working at the intersection of software, hardware, and molecular science to drive the digital transformation of the manufacturing industry. Prior to this, Joe was the Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, and William R. Kenan, Jr. Distinguished Professor of Chemical Engineering at NC State University and of Chemistry at UNC. He has published more than 350 scientific articles and has nearly 200 issued patents in his name, with more than 200 patents pending. Joe has mentored and trained 80 Ph.D. students in his career, half of whom are women and other members of underrepresented minority groups in the sciences. Joe is one of only roughly 20 individuals who have been elected to all three branches of the U.S. National Academies: the National Academy of Medicine (2014), the National Academy of Sciences (2012), and the National Academy of Engineering (2005). He is also a member of the American Academy of Arts and Sciences (2005). Joe has received more than 50 major awards and recognitions, including the 2018 National Academy of Sciences Award for Convergent Science; the 2017 $250,000 Heinz Award for Technology, the Economy and Employment; the U.S. National Medal of Technology and Innovation, awarded by President Barack Obama in 2016; the inaugural $250,000 Kabiller Prize in Nanoscience and Nanomedicine; the 2015 Dickson Prize from Carnegie Mellon University; the 2014 Kathryn C. Hach Award for Entrepreneurial Success from the ACS; the 2012 Walston Chubb Award for Innovation by Sigma Xi; the 2010 AAAS Mentor Award in recognition of his efforts to advance diversity in the chemistry PhD workforce; the 2009 NIH Director's Pioneer Award; the 2009 North Carolina Award; the 2008 $500,000 Lemelson-MIT Prize for Invention and Innovation; the 2005 ACS Award for Creative Invention; the 2002 John Scott Award presented by the City Trusts, Philadelphia, given to "the most deserving" men and women whose inventions have contributed in some outstanding way to the "comfort, welfare and happiness" of humankind; and the 2002 Engineering Excellence Award by DuPont. In addition to Carbon, Joe is the co-founder of several companies including Micell Technologies, Bioabsorbable Vascular Solutions, and Liquidia Technologies. He received his B.S. in Chemistry in 1986 from Ursinus College in Collegeville, PA and his Ph.D. in Chemistry in 1990 from Virginia Tech. He currently resides in Monte Sereno, California with his wife of 30 years, Suzanne.
Larry Kessler is the UW Center for Dialysis Innovation Director of Regulatory Oversight, and Professor in the UW Department of Health Services in the School of Public Health. He has over 30 years of experience in health services research. He came to the University of Washington from US Food and Drug Administration (FDA) where he served as the director of both the Office of Surveillance and Biometrics and the Office of Science and Engineering Laboratories at the Center for Devices and Radiological Health. Dr. Kessler's work in cancer surveillance with the Applied Research Branch at NCI substantially changed the way in which cancer surveillance is performed, with the addition of the Cancer supplements to the National Health Interview Survey, the SEER-Medicare data system, and the Breast Cancer Screening Consortium and the Breast Cancer Surveillance Consortium. He has an extensive research record in applied health services research with special work in regulatory knowledge of medical products and use of technologies in medical care. In addition to his role in regulatory oversight for the CDI, he co-leads the human factors research team.
Research Interests:
Cost-effectiveness and diagnostic value of medical technology in screening for cancer and other diseases
Education & Training: Sc.D., Johns Hopkins University, 1978 (Health Services Admin)
B.S., Boston University, 1973 (Mathematics) External: View publications
Dr. Larry Kessler, ScD, is the Director of Regulatory Oversight for the Center for Dialysis Innovation, and Professor in the Department of Health Services in the School of Public Health at the University of Washington.
Job Titles:
- Associate Professor at Civil & Environmental Engineering Department
- Director of Gut Engineered Treatment Using Polymers ( GETUP ) )
Dr. Winkler (Mari) is an associate Professor at Civil & Environmental Engineering Department at the University of Washington. During her scientific career she studied at the University Duisburg Essen (DE) in the Chemistry Department, at University of British Columbia (CA) in the Microbiology and Immunology Department, at Columbia University (US) in the Earth and Environmental Engineering Department, and at the University of New South Wales (AU) in the Marine-Microbiology Department. She received her PhD from the Environmental Biotechnology Department at Delft University of Technology (NL) and worked in the Biosystems Engineering Department at the Ghent University (BE) with Europe's most prestigious Post-Doctoral fellowship (Marie Curie).
Her research focuses on the removal of phosphate, nitrogen, and carbon from various environments including wastewater, terrestrial systems, as well as the human gut. At the Center of Dialysis Innovation, her team is pioneering a novel path forward to utilize engineering principle inspired by wastewater treatment biology to combat Chronic Kidney Disease by removing uremic toxin pre-cursors from the gut before they cross the gut-blood barrier hence avoiding or delaying the need for the physically and mentally draining dialysis treatment. Dr. Winkler's team is exploiting chemical binders, enzymes, and life bacteria encapsulated in pH responsive polymers (comparable to the popular bubble tea drink) that are ingested by a patient to remove uremic toxins from the gut.
Job Titles:
- Certified Surgeon at the Vascular
- Vascular Surgery
Elina Quiroga is a board-certified surgeon at the Vascular and Endovascular Surgery Clinic at Harborview Medical Center. She is also a University of Washington assistant professor of Surgery. Dr. Quiroga believes in creating active partnerships with her patients to achieve the best possible outcomes. Her scope of care includes management of peripheral vascular disease, aortic aneurysms, vascular trauma and dialysis access, and using open and endovascular techniques. Dr. Quiroga earned her M.D. from Universidad de Buenos Aires in Argentina. She is board-certified in general surgery and vascular surgery, and is a fellow of the American College of Surgery. Her clinical interests include general vascular surgery, aortic surgery, vascular trauma, peripheral vascular disease and dialysis access. Her research interests include improving surgical education worldwide, especially on methods and conditions relevant to low and middle-income countries and women's participation in surgery.
Emmett is a recent transplant recipient, and was featured on the cover of Northwest Kidney Center's 2014 annual report along with his family. IgA nephropathy came as a shock to Emmett as due to his age and that he had always been healthy. When his kidneys failed, he did peritoneal dialysis treatments at home for a few months and later transitioned to NKC's clinic in Renton. Emmett juggles many responsilities with his job enforcing safety at an indoor shooting range, and family time with wife Esther and baby Arianna. Emmett has been successful in community fund-raising for NKC and is very interested in kidney disease research and novel dialysis technologies.
Job Titles:
- Director of External Relations and Patient Engagement for the Center of Dialysis Innovation
- Director or External Relations & Patient Engagement )
Prior to joining the UW Center for Dialysis Innovation and Kidney Research Institute as the Director of External Relations & Patient Engagement, Glenda V. Roberts was an Information Technology executive with over 35 years of experience. Before going on dialysis, Glenda managed the progression of her disease throughout her career via diet and exercise for over 40 years. Refusing to accept limitations, she enjoyed a fulfilling career, evolving from a software developer to a senior business executive managing multi-million-dollar business units for top-caliber corporations, including General Electric, Microsoft and Johnson & Johnson. Since her transplant in 2010, she's completed eight half marathons.
Based upon her personal experience with kidney disease, Glenda is a passionate activist for kidney research and patients living with kidney disease. She's involved in myriad patient-centered national and international health care transformation initiatives. All are focused on addressing patient preferences and improving patient reported outcomes. She was recently named to the Kidney Health Initiative (KHI) Patient and Family Partnership Council. The KHI is a public-private partnership between the American Society of Nephrology (ASN) and the US Food and Drug Administration (FDA) to help foster the development of new products to improve the lives of people living with kidney diseases. Glenda was appointed as only the second patient to serve on the Canadian Can-SOLVE CKD International Research Advisory Committee. She was among the patient partners in attendance at the International Society of Nephrology (ISN) Research Collaborative Meeting and 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials. In addition serving on the CDI Patient Advisory Board, the Patient Advisory Committee for the Kidney Research Institute, and the Home Dialyzors United Advisory Board, Glenda brings the patient voice to a number of NIH/NIDDK government (the APOL1 Community Advisory Board; the Kidney Precision Medicine Project Community Engagement Committee; the APOLLO Community Advisory Committee) and industry (APOL1 Delphi) research efforts. She is also an equal member of the CDI Leadership team, the CDI Port R&D project and the CDI Human Factors Working Group.
Glenda V. Roberts is the Director of External Relations and Patient Engagement for the Center of Dialysis Innovation (CDI). She received her BS in Mathematics from the University of Houston in Houston, Texas.
Job Titles:
- Chief
- Chief, Division of Nephrology, Stanford
- Chief, Division of Nephrology, Stanford University School of Medicine
- Professor
Chief, Division of Nephrology, Stanford University School of Medicine Norman S. Coplon Satellite Healthcare Professor in Medicine, Division of Nephrology, Stanford University School of Medicine Dr. Chertow, MD, MPH, is Professor of Medicine and Chief of the Division of Nephrology
Dr. Chertow, MD, MPH, is Professor of Medicine and Chief of the Division of Nephrology at Stanford University School of Medicine. Prior to joining the faculty at Stanford, Dr. Chertow served with distinction on the faculties at Brigham and Women's Hospital and Harvard Medical School (1995-98) and the University of California San Francisco (UCSF) (1998-2007). Dr. Chertow has established a successful career as a clinical investigator and continues to maintain a productive research program focused on improving care for persons with acute and chronic kidney disease. Recent projects include several NIDDK-sponsored initiatives: Acute Renal Failure Trials Network (ATN) Study, the United States Renal Data System (USRDS) Special Studies Center in Nutrition, the Chronic Renal Insufficiency Cohort (CRIC) study and the Frequent Hemodialysis Network (FHN) study. Dr. Chertow was elected to the National Academy of Medicine in 2015, one of the only nephrologists among the academy's more than 2,000 distinguished members who are elected in recognition of professional achievement and commitment to service. He was elected to the American Society of Clinical Investigation in 2004 and appointed to the Scientific Advisory Board of the National Kidney Foundation in 2007. He was Vice Chair and member of two workgroups for the Kidney Disease Quality Outcomes Initiative (K/DOQI) and Associate Editor of the Journal of the American Society of Nephrology. Dr. Chertow has authored more than 400 medical publications, and is an editor of the 9th edition of Brenner & Rector's The Kidney. Dr. Chertow also received the 2007 National Torchbearer Award from the American Kidney Fund for his career-long contributions toward improving the lives of persons with kidney disease. Dr. Chertow received his medical degree from Harvard Medical School, his Master of Public Health from the Harvard School of Public Health in epidemiology and biostatistics, performed his residency and fellowship at Brigham and Women's Hospital, Harvard Medical School, and is board certified in nephrology. His major medical research interests include clinical epidemiology, health services research, decision sciences, and clinical trials in acute and chronic kidney disease.
Jennifer Jones is a two-time kidney transplant recipient (first from an altruistic living donor in 4/2015 and second deceased donor 11/ 2021). In 2011 while serving in the United States Marines as a Combat Camera Videographer, her kidneys declined while forward deployed to Afghanistan. After being medically evacuated back to the states, she was diagnosed with Membranoproliferative Glomerulonephritis, Type 1 Idiopathic. She is currently the Vice President of the American Association of Kidney Patients, a member of the Center for Dialysis Innovation Patient Advisory Board, the Patient and Family Advisory Council of Quality Insights Renal Network 5, the National KCER Patient and Family Engagement Learning and Action Network, the Veterans Transplantation Association, and Kindness for Kidneys. She is passionate about advocacy for policies that improve the quality of life for the kidney patient and their families, patient-centered education, community building, and removing barriers to living organ donation and innovation.
Jeremy Barribeau holds a BDes (Hons) in industrial design (Victoria University, Wellington, New Zealand), and an MDes in interaction design (University of Washington, Seattle, USA). He is the Concept and Experience Design Lead at the Center for Dialysis Innovation (CDI) and at Kuleana Technology Inc., and a guest lecturer at the University of Washington.
Jeremy has 10+ years of experience designing physical and digital products as an in-house designer and consultant for companies ranging in size from startups to the Fortune 50. His product design experience spans the gamut, from bespoke to high volume (millions of units), and includes soft-goods, packaging, medical devices, consumer electronics and enterprise/industrial electronics products. His design and innovation work has been recognized with multiple patents and design awards, including the Red Dot and iF awards. Jeremy specializes in human-centered design (HCD) and is equally at home designing blue-sky conceptual products as he is designing for mass-manufacturing (DFM).
Job Titles:
- Assistant Professor in the Industrial and Systems Engineering Department at the University of Washington
Ji-Eun Kim is an assistant professor in the Industrial and Systems Engineering Department at the University of Washington. She holds a Ph.D. degree in Industrial Engineering from the Pennsylvania State University and a M.S. degree in Cognitive Psychology from Korea University. Her primary research focuses on measuring, modeling, and designing human performance considering individual differences by employing statistical, physiological, and psychological measurements. She is also interested in the application of the individualized performance to healthcare, operations research, and engineering education. Her work is rooted in her previous study of cognitive neuroscience which was funded by government agencies and industry partners. Before joining Penn State, she worked for the Korea Institute of Science of Technology on a project to develop biomedical robots that automatically respond to users' muscular signals.
Job Titles:
- the Department Chair of Chemical Engineering
Jim Pfaendtner is the Department Chair of Chemical Engineering, holds the Jagjeet and Janice Bindra Endowed Career Development Professorship in Chemical Engineering, and is Adjunct Professor in Chemistry, at the University of Washington. His group uses computer simulations to understand and control molecular scale driving forces for a wide range of applications spanning biotechnology to materials synthesis. His group develops new methods that expand the capabilities of molecular simulation and uses advanced research computing resources to solve challenging problems in the area of computational molecular science, data science and machine learning, and reaction engineering.
Job Titles:
- Endowed Chair in Kidney Research, University of Washington
Job Titles:
- Director of Translation & Operations for the UW Center for Dialysis Innovation
- Director of Translational Research and Commercialization for the Center for Dialysis Innovation
- Director of Translational Research, Commercialization, & Operations, Bioengineering )
Dr. Kassandra Thomson, PhD, is the Director of Translational Research and Commercialization for the Center for Dialysis Innovation.
Kassandra Thomson is the Director of Translation & Operations for the UW Center for Dialysis Innovation. Previously, she was the Director of the UW Coulter Translational Research Partnership Program, a gap funding program for early stage medical device technologies being developed at UW. Over the 11 year span of the program, the UW Coulter TRP portfolio of funded projects led to over 40 startups and licensing deals. She has consulted for multiple biotechnology companies in the Seattle area. Dr. Thomson received her PhD in Bioengineering from UW in 2013, during which time she was awarded a National Science Foundation Graduate Research Fellowship and an American Heart Association Fellowship for her graduate research in cardiac tissue engineering, where she took a leading role in a multi-investigator NIH-sponsored project to develop engineered cardiac tissue constructs to treat heart failure. Dr. Thomson earned a Technology Entrepreneurship Certificate from the UW Foster School of Business, and was an Institute of Translational Health Sciences/Washington Research Foundation Fellow with the UW Center for Commercialization (now CoMotion).
Job Titles:
- Founding Partner, Convergency
Biography
Larry's vision for Convergency followed his experiences as a senior executive at two leading mission-driven organizations. At Juvenile Diabetes Research Foundation (JDRF), one of the nation's most successful and active patient advocacy and research organizations, Larry built an advocacy program that was cited by the media as among the most powerful in Washington DC. Larry chaired the successful national campaign to advance stem cell research, and he secured more than $2 billion in mandatory federal diabetes funding, the only disease area to get such funding. He went on to serve as Chief Operating Officer with oversight responsibility for most major activities within the organization. Following his time at JDRF, Larry served as CEO for the Partnership for a Healthier America, where he worked with PHA Honorary Chair Michelle Obama and PHA Vice Chairs Senator Cory Booker (D-NJ) and former Senate Majority Leader Bill Frist (R-TN) on corporate partnerships that produced win/win outcomes for both public health and company brands and budgets. Larry developed more than 250 such partnerships and raised more than $60 million during his time at PHA.
Job Titles:
- Associate Editor for the Journal Accident Analysis
- Director of the Human Factors
Linda Ng Boyle joined the Industrial & Systems Engineering Department at University of Washington as an associate professor in Fall 2009. Prior to this appointment, she was an associate professor at the University of Iowa and a senior researcher at the U.S. Department of Transportation-Volpe Center. Dr. Boyle's research centers on driving behavior, crash countermeasures, crash and safety analysis, and statistical modeling. She is the recipient of an NSF Career Award. Her research work has also been funded by the US DOT, NIH, and the National Academies-TRB.
Dr. Boyle is an associate editor for the journal Accident Analysis and Prevention and serves on the Transportation Research Board committees on Simulation and Measurement of Vehicle and Operator Performance and Statistical Methodology in Transportation Research. She also co-organizes the International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design.
Dr. Boyle is the director of the Human Factors and Statistical Modeling Lab.
Research Interests:
Adaptation to vehicle automation and in-vehicle technology
Human-system interactions in manufacturing
Education & Training: Ph.D., Civil and Environmental Engineering, University of Washington
M.S., Industrial Engineering/Inter-Engineering, University of Washington
B.S., Industrial Engineering, State University of New York at Buffalo
Job Titles:
- Chief Clinical Officer
- Chief Clinical Officer & Senior Vice President, ADVI
Chief Clinical Officer & Senior Vice President, ADVI Dr. Jacques is Chief Clinical Officer and a Senior Vice President at ADVI, a health care advisory services firm. He also serves on several institutional boards and advisory panels. Before joining ADVI
Dr. Jacques is Chief Clinical Officer and a Senior Vice President at ADVI, a health care advisory services firm. He also serves on several institutional boards and advisory panels. Before joining ADVI in 2014, Dr. Jacques was the Director of the Coverage and Analysis Group (CAG) in the Centers for Medicare & Medicaid Services (CMS) from 2009 - 2014, where he managed Medicare fee for service coverage policy development on technologies as diverse as molecular diagnostic testing, implanted cardiac devices, advanced imaging, chemotherapeutics, wound care, and screening and preventive services. From 2004 - 2009 he was a division director within CAG, focusing on Part B drugs and diagnostic tests. Before joining CMS in 2003, Dr. Jacques was Associate Dean for Curriculum at Georgetown University School of Medicine, where he saw patients at the Lombardi Cancer Center in his practice of hospice and palliative medicine.
Job Titles:
- WW President, BD Surgery, Becton Dickinson
WW President, BD Surgery, Becton Dickinson Affiliate Associate Professor, Department of Bioengineering, University of Washington Dr. Garrison is the WW President of the Becton Dickinson (BD) Interventional-Surgery Business Unit, responsible for developing advanced solutions for tissue reconstruction, optimized surgical process
Dr. Garrison is the WW President of the Becton Dickinson (BD) Interventional-Surgery Business Unit, responsible for developing advanced solutions for tissue reconstruction, optimized surgical process outcomes, infection risk reduction, and palliative care. Prior to his current position, Mike has held a series of roles of increasing technical and business responsibility including: WW Vice-President and General Manager, BD Infusion Solutions, Vice President of R&D, BD Medication and Procedural Solutions, Senior Business Director, BD Hypodermic and Anesthesia Systems, and Director of Advanced Technology. Prior to BD, Dr. Garrison served as Manager of R&D for the surgical heart valve franchise at Edwards Lifesciences, Global Marketing Manager at Roche Diagnostics, and as a Research Scientist at Cygnus Therapeutic Systems. Dr. Garrison received BS and MS degrees in biomedical engineering from Duke University, and a PhD in bioengineering from the University of Washington, where he was advised by Dr. Buddy Ratner. He currently and previously has served on the boards of a number of investment companies of BD. He is currently an Affiliate Associate Professor in the University of Washington Department of Bioengineering.
Nichole Jefferson, who currently resides in Dallas, TX, was diagnosed with end-stage renal disease in 2003 and experienced both forms of dialysis (HD and PD). On June 12, 2008, she received the gift of life, a kidney transplant. Due to the many obstacles she faced following her transplant, Nichole realized that a transplant was simply another form of treatment and not a cure. This realization initiated her enthusiasm for advocacy. Nichole shares her story with her community and underserved populations and speaks with legislators regarding the need for early detection and other issues relating to chronic kidney disease. She became a Field Ambassador for the American Association of Kidney Patients in 2017, joined the Home Dialyzors United (HDU) Board of Directors in 2017 and was recently elected President of the Board. In addition, she serves on the Kidney Precision Medicine Project Community Engagement Committee and is the co-leader of the NIDDK APOLLO Community Advisory Board.
Senior Fellow, von Liebig Entrepreneurism Center, School of Engineering, University of California San Diego Adjunct Professor, Department of Bioengineering, University of California San Diego Former Vice President, Technology Policy & Academic Relations, Medtronic
Job Titles:
- Professor of Bioengineering, University
Robert F. Rushmer Professor of Bioengineering, University of Washington Adjunct Professor, Department of Chemical Engineering, University of Washington Dr. Suzie Pun, PhD, is the Robert F. Rushmer Professor of Bioengineering, an Adjunct Professor of Chemical Engineering. She is a fellow
Job Titles:
- Professor of Medicine at the University of North Carolina School of Medicine
- Professor of Medicine, Division
Professor of Medicine, Division of Nephrology and Hypertension, UNC School of Medicine Dr. Hostetter is a Professor of Medicine at the University of North Carolina School of Medicine, Division of Nephrology and Hypertension. Previously, he was a Professor of Medicine
Job Titles:
- Distinguished Professor of Chemical Engineering at North Carolina State University and of Chemistry at UNC - Chapel Hill
Dr. Joseph M. DeSimone is the CEO and co-founder of Carbon, Inc., a Silicon Valley-based company working at the intersection of software, hardware, and molecular science to drive the digital transformation of the manufacturing industry. Prior to this, Joe was the Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, and William R. Kenan, Jr. Distinguished Professor of Chemical Engineering at NC State University and of Chemistry at UNC. He has published more than 350 scientific articles and has nearly 200 issued patents in his name, with more than 200 patents pending. Joe has mentored and trained 80 Ph.D. students in his career, half of whom are women and other members of underrepresented minority groups in the sciences. Joe is one of only roughly 20 individuals who have been elected to all three branches of the U.S. National Academies: the National Academy of Medicine (2014), the National Academy of Sciences (2012), and the National Academy of Engineering (2005). He is also a member of the American Academy of Arts and Sciences (2005). Joe has received more than 50 major awards and recognitions, including the 2018 National Academy of Sciences Award for Convergent Science; the 2017 $250,000 Heinz Award for Technology, the Economy and Employment; the U.S. National Medal of Technology and Innovation, awarded by President Barack Obama in 2016; the inaugural $250,000 Kabiller Prize in Nanoscience and Nanomedicine; the 2015 Dickson Prize from Carnegie Mellon University; the 2014 Kathryn C. Hach Award for Entrepreneurial Success from the ACS; the 2012 Walston Chubb Award for Innovation by Sigma Xi; the 2010 AAAS Mentor Award in recognition of his efforts to advance diversity in the chemistry PhD workforce; the 2009 NIH Director's Pioneer Award; the 2009 North Carolina Award; the 2008 $500,000 Lemelson-MIT Prize for Invention and Innovation; the 2005 ACS Award for Creative Invention; the 2002 John Scott Award presented by the City Trusts, Philadelphia, given to "the most deserving" men and women whose inventions have contributed in some outstanding way to the "comfort, welfare and happiness" of humankind; and the 2002 Engineering Excellence Award by DuPont. In addition to Carbon, Joe is the co-founder of several companies including Micell Technologies, Bioabsorbable Vascular Solutions, and Liquidia Technologies. He received his B.S. in Chemistry in 1986 from Ursinus College in Collegeville, PA and his Ph.D. in Chemistry in 1990 from Virginia Tech. He currently resides in Monte Sereno, California with his wife of 30 years, Suzanne.
Job Titles:
- Director, McGowan Institute for Regenerative Medicine
Director, McGowan Institute for Regenerative Medicine, University of Pittsburgh Professor, Surgery, Bioengineering, and Chemical Engineering, University of Pittsburgh